Are you finishing strong in cell therapy manufacturing? Tackling your final fill and finish challenges with automation

Cell & Gene Therapy Insights 2021; 7(9), 1163–1171


Published: 11 November 2021
Innovator Insight

Fill and finish is a critical, high-value step in cell therapy manufacturing; failure is both costly for the manufacturer and potentially catastrophic for the patient waiting to receive therapy. This key step is frequently done manually, which poses a number of significant risks. In contrast, the Finia® Fill and Finish System, designed to automate this process, may reduce contamination and labor costs while improving reproducibility and supporting GMP compliance.